Social and ethical aspects of pharmacogenomics in psychiatry

Nikolas Rose

doi:10.1016/j.mppsy.2006.11.005

Social and ethical aspects of pharmacogenomics in psychiatry

Nikolas Rose^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

5 Citations (Scopus)

Abstract

This contribution outlines some of the key economic, social and ethical issues and dilemmas raised by the increasing interest in pharmacogenomics in psychiatric drug development in research and clinical settings.

Original language	English
Pages (from-to)	80-82
Number of pages	3
Journal	Psychiatry
Volume	6
Issue number	2
DOIs	https://doi.org/10.1016/j.mppsy.2006.11.005
Publication status	Published - Feb 2007
Externally published	Yes

Access to Document

10.1016/j.mppsy.2006.11.005

Cite this

@article{dc787c856f8147aa8c6c917ff7053f9d,

title = "Social and ethical aspects of pharmacogenomics in psychiatry",

abstract = "This contribution outlines some of the key economic, social and ethical issues and dilemmas raised by the increasing interest in pharmacogenomics in psychiatric drug development in research and clinical settings.",

keywords = "confidentiality, consent, pharmacogenomics, psychiatry, social and ethical issues",

author = "Nikolas Rose",

year = "2007",

month = feb,

doi = "10.1016/j.mppsy.2006.11.005",

language = "English",

volume = "6",

pages = "80--82",

journal = "Psychiatry",

issn = "1476-1793",

publisher = "Medicine Publishing Company Ltd.",

number = "2",

}

TY - JOUR

T1 - Social and ethical aspects of pharmacogenomics in psychiatry

AU - Rose, Nikolas

PY - 2007/2

Y1 - 2007/2

N2 - This contribution outlines some of the key economic, social and ethical issues and dilemmas raised by the increasing interest in pharmacogenomics in psychiatric drug development in research and clinical settings.

AB - This contribution outlines some of the key economic, social and ethical issues and dilemmas raised by the increasing interest in pharmacogenomics in psychiatric drug development in research and clinical settings.

KW - confidentiality

KW - consent

KW - pharmacogenomics

KW - psychiatry

KW - social and ethical issues

UR - https://www.scopus.com/pages/publications/33846840696

U2 - 10.1016/j.mppsy.2006.11.005

DO - 10.1016/j.mppsy.2006.11.005

M3 - Review article

SN - 1476-1793

VL - 6

SP - 80

EP - 82

JO - Psychiatry

JF - Psychiatry

IS - 2

ER -

Social and ethical aspects of pharmacogenomics in psychiatry

Abstract

Access to Document

Other files and links

Fingerprint

Cite this